SPHQ Outpaced JQUA by 500 Basis Points Over Five Years Despite Being the Riskier Trade
If you want a quality-factor tilt on U.S. large caps, the two cleanest options are the Invesco S&P 5…

Paging subscriber unit churn rate: Quarterly net subscriber losses exceeding 3-4% trigger valuation compression as investors extrapolate terminal value concerns
Software revenue growth trajectory: Any acceleration in Spok Care Connect adoption signals successful business model transition and commands premium multiples
Capital allocation announcements: Special dividends or share buyback authorizations drive near-term price appreciation given high FCF conversion
Healthcare IT spending trends: Hospital capital expenditure cycles for clinical communication infrastructure upgrades directly impact software segment bookings
low - Healthcare communication infrastructure exhibits minimal GDP sensitivity as hospitals maintain critical messaging systems regardless of economic conditions. However, discretionary software upgrade cycles may defer during severe recessions when hospital operating margins compress. The paging business is effectively non-cyclical with predictable attrition, while software sales show modest correlation to healthcare provider capital budgets.
Rising interest rates create modest headwinds through two channels: (1) Higher discount rates compress valuation multiples for declining cash flow streams, particularly impacting terminal value assumptions for the legacy paging business; (2) Increased financing costs for hospital customers may delay discretionary IT modernization projects, slowing software segment growth. However, Spok maintains minimal debt (0.05x D/E), eliminating direct interest expense sensitivity. The company's high FCF yield (9.2%) becomes relatively more attractive in low-rate environments versus fixed income alternatives.
Technological obsolescence of paging infrastructure: Smartphone proliferation and 5G network reliability improvements accelerate migration away from dedicated paging devices, potentially compressing the legacy business runway from 8-10 years to 5-7 years
Regulatory changes to healthcare communication standards: Updates to HIPAA technical safeguards or Joint Commission requirements could either mandate costly infrastructure upgrades or alternatively reduce barriers to competitive smartphone-based solutions
Healthcare consolidation reducing customer count: Hospital M&A activity leads to system standardization decisions that may favor larger competitors like Vocera (acquired by Stryker) or Epic-integrated communication tools
value - The stock attracts deep value investors focused on high FCF yields (9.2%) and potential for return of capital through dividends or buybacks. The declining revenue profile and low growth prospects deter growth investors, while the business model transition creates uncertainty unsuitable for conservative income investors. Typical shareholders include quantitative value funds, special situations investors betting on accelerated capital returns, and contrarian healthcare specialists identifying potential software segment inflection points. The compressed valuation (2.0x P/S, 10.0x EV/EBITDA) reflects market skepticism about long-term viability.
Trend
+26.1% vs SMA 50 · +404.4% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $138.3M $138.3M–$138.3M | — | $0.77 | — | — | Low1 |
FY2024 | $139.2M $139.2M–$139.2M | ▲ +0.7% | $0.76 | ▼ -1.3% | — | Low1 |
FY2025 | $140.5M $140.5M–$140.5M | ▲ +0.9% | $0.80 | ▲ +5.3% | — | Low1 |
Dividend per payment — last 8 periods
If you want a quality-factor tilt on U.S. large caps, the two cleanest options are the Invesco S&P 5…

spok, inc., a wholly owned subsidiary of spok holdings, inc. (nasdaq: spok), headquartered in springfield, va., is proud to be the global leader in healthcare communications. we deliver clinical information to care teams when and where it matters most to improve patient outcomes. top hospitals rely on the spok care connect® platform to enhance workflows for clinicians, support administrative compliance, and provide a better experience for patients. our customers send over 100 million messages each month through their spok® solutions. when seconds count, count on spok. for more information, visit spok.com or follow @spoktweets on twitter.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
SPOK◀ | $10.85 | -0.73% | $227M | 17.8 | +149.3% | 1136.7% | 1500 |
| $396.78 | -1.07% | $4.8T | 30.0 | +1512.6% | 3280.0% | 1523 | |
| $393.32 | -0.97% | $4.8T | 30.0 | +1512.6% | 3280.0% | 1522 | |
| $614.23 | -0.68% | $1.6T | 22.1 | +2216.7% | 3008.4% | 1501 | |
| $87.02 | +0.09% | $366.4B | 27.5 | +1585.1% | 2430.4% | 1479 | |
| $185.22 | -1.58% | $200.4B | 19.3 | +848.8% | 1244.7% | 1485 | |
| $46.37 | -1.47% | $193.6B | 11.2 | +252.5% | 1242.8% | 1505 | |
| Sector avg | — | -0.91% | — | 22.5 | +1153.9% | 2231.8% | 1502 |